ArticleInternal medicine (Tokyo, Japan)2024

PD-L1-negative Non-small-cell Lung Cancer Treated with Nivolumab Plus Ipilimumab during Maintenance Hemodialysis Results in Rapid Initial Progression Followed by a Long-lasting Response.

Shohei Yano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.